Hepatitis C virus (HCV) is a global public health problem involving chronic infection of the
liver, which can cause liver disease and is linked with liver cancer. Viral innate immune …

Genome-wide association studies (GWAS) have recently identified host genetic variation to
be critical for predicting treatment response and spontaneous clearance in patients infected …

Genetic variation near the IL28B gene and substitution of amino acid (aa) 70 and 91 in the
core region of hepatitis C virus (HCV) genotype 1b can predict the response to pegylated …

The current recommended therapy for chronic hepatitis C is the combination of peginterferon
and ribavirin, which results in a sustained clearance of hepatitis C virus (HCV) in at least half …

Hepatitis C virus (HCV) is a common RNA virus that causes hepatitis and liver cancer.
Infection is treated with IFN-α and ribavirin, but this expensive and physically demanding …

Hepatitis C virus (HCV) is a major cause of liver disease worldwide. HCV is able to evade
host defense mechanisms, including both innate and acquired immune responses, to …

The nucleotide sequence diversity present among hepatitis C virus (HCV) isolates allows
rapid adjustment to exterior forces including host immunity and drug therapy. This viral …

Abstract Purpose: Hepatitis C virus (HCV) infection can promote the development of
hepatocellular carcinoma (HCC). Published data implicate the HCV core gene in …

Natural killer (NK) cells constitute a first line of defense against viral infections; their function
is governed by the integration of signals from multiple activating and inhibitory surface …

BK polyomavirus (BKPyV or BKV) is a non‐enveloped, circular double‐stranded DNA virus
that may exceed 80% seroprevalence in adults. BKV infection typically occurs during …